Health
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
UCB, a global biopharmaceutical company, today shared results from the "Rheum for Improvement" survey that sought to further understand unmet needs among patients living with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), which includes both non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS).
About this update from Ucb S.a.
[{"type":"list","items":[{"val":[{"type":"text","content":"Survey insights reveal that despite many participants living with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), which includes both non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS), feeling misunderstood, a significant majority remain open to dialogue—74% of the 34 Gen Z and 67% of the 216 Millennials surveyed are willing to discuss their diagnoses with loved ones.1","length":419,"tagName":"p"}]},{"val":[{"type":"text","content":"Chronic fatigue emerged as a pressing unmet need, with 60% of the 50 AS and nr-axSpA and 36% of the 200 PsA respondents identifying the management of this symptom as an unmet need not currently addressed in their care.1","length":219,"tagName":"p"}]},{"val":[{"type":"text","content":"Across all surveyed age groups, pain management stood out as a leading treatment goal, with nearly 80% of the 250 participants citing it as a priority.1","length":152,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":790,"olType":false},{"type":"text","content":"ATLANTA, Sept. 10, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today shared results from the "Rheum for Improvement" survey that sought to further understand unmet needs among patients living with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), which includes both non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS).","length":397,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/UCB, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/UCB, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":95,"url":"https://media.zenfs.com/en/prnewswire.com/b8934a241b3f4be76014bb4ac3438a0c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xSTzopCi9exEzsCW8PHvIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE2NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b8934a241b3f4be76014bb4ac3438a0c","width":400,"height":95}},"href":"https://mma.prnewswire.com/media/677397/With_Tag_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The survey revealed there is still "Rheum for Improvement"—especially in areas like misunderstanding of these conditions among patients' friends and family, unmet treatment and symptom management needs, and...